Imunon, Inc. (NASDAQ:IMNN) Q2 2025 Earnings Call Transcript
Operator: Good morning. My name is Darwin, and I will be your operator today. At this time, I would like to welcome you to IMUNON's Second Quarter 2025 Financial Results Conference Call.
Imunon Inc. (IMNN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sabby Capital Hal Mintz | 60,000 | $720,000 | 1.31% | |
| 2. | Renaissance Technologies Jim Simons | 42,533.333,333,333 | $510,400 | +6010% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.18 | 25,000 | $29,480.00 | 25,597 | 2024-08-20 | Filing | |
| $0.98 | 25,000 | $24,500.00 | 264,166 | 2024-08-15 | Filing | |
| $1.03 | 25,000 | $25,750.00 | 353,346 | 2024-08-15 | Filing | |
| $3.53 | 4,000 | $14,129.20 | 16,513 | 2022-04-12 | Filing | |
| $4.05 | 5,000 | $20,250.00 | 11,766 | 2022-04-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.08 | 5,556 | $11,578.15 | 2,421,867 | 2015-12-03 | Filing | |
| $2.15 | 15,000 | $32,202.00 | 2,427,423 | 2015-12-01 | Filing | |
| $2.15 | 20,000 | $43,048.00 | 2,442,423 | 2015-11-30 | Filing | |
| $2.11 | 10,000 | $21,121.00 | 2,462,423 | 2015-09-08 | Filing | |
| $2.19 | 10,000 | $21,900.00 | 2,472,423 | 2015-08-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1 | $5 | 0% | |
| 2. | 1 | $5 | 0% | |
| 3. | 0 | $0 | 0% |
News See All
Why Imunon, Inc. (IMNN) Surged Last Week
We recently published a list of Small Stocks, But Explosive: These 10 Firms Crushed The Market Last Week.
Imunon, Inc. (IMNN) Raises $3.25M in Private Placement, Eyes $6.5M More
Imunon, Inc. (NASDAQ:IMNN) has completed a private placement, securing $3.25 million in initial funding by selling 7,222,223 shares of common stock or pre-funded warrants at $0.45 each.
Imunon, Inc. (NASDAQ:IMNN) Q1 2025 Earnings Call Transcript
Operator: Good morning. My name is Dave, and I will be your operator today. At this time, I would like to welcome you to Imunon's First Quarter 20254 Financial Results Conference Call.
Imunon, Inc. (NASDAQ:IMNN) Q4 2024 Earnings Call Transcript
Operator: Good morning. My name is Mike, and I will be your operator today. At this time, I would like to welcome you to Imunon, Inc.'s full year 2024 financial results Conference Call.
Imunon, Inc. (NASDAQ:IMNN) Q3 2024 Earnings Call Transcript
Operator: Hello everyone. Good morning. My name is Malone, and I will be your operator today.
Imunon, Inc. (NASDAQ:IMNN) Q2 2024 Earnings Call Transcript
Operator: Good morning, everyone. My name is Jamie, and I will be your operator today.
Imunon, Inc. (NASDAQ:IMNN) Q1 2024 Earnings Call Transcript
Operator: Good morning. My name is Nick and I will be your operator today. At this time, I would like to welcome you to the Imunon First Quarter 2024 Financial Results Conference Call.
Imunon, Inc. (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript
Imunon, Inc. beats earnings expectations. Reported EPS is $-0.52, expectations were $-0.59. Imunon, Inc.
Imunon, Inc. (NASDAQ:IMNN) Q3 2023 Earnings Call Transcript
Operator: Good morning. My name is Alan, and I will be your operator today. At this time I would like to welcome you to Imunon's Third Quarter 2023 Financial Results Conference Call.
Hedge Fund Resource Center Billionaire Hedge Funds
